Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Clarma Capital is a venture capital firm established to support European life sciences startups, particularly in medical devices, medicinal products, and diagnostic innovation. Founded with the mission to nurture breakthroughs in the life sciences sector, Clarma Capital operates from multiple locations, including London, Switzerland, Dublin, and Central Europe. The firm is dedicated to fostering innovation in healthcare through strategic investments.
Currently, Clarma Capital is led by a team of experienced professionals, including Managing Partner Martyn Eeles. The firm focuses on seed and early-stage investments, emphasizing collaboration with incubators, innovation hubs, and academic institutions. Clarma Capital seeks to partner with companies that have significant addressable markets and capable management teams, aiming for clear exit strategies through acquisitions or mergers.
Clarma Capital invests primarily in seed and early-stage European life sciences companies that are developing regulated products based on solid scientific principles. The firm targets sectors such as biotech and healthcare, with a particular interest in medical devices, medicinal products, and diagnostic innovation. Clarma Capital looks for companies that demonstrate significant addressable markets and possess capable management teams.
The investment strategy emphasizes collaboration with incubators, innovation hubs, and academic institutions, which enhances the potential for successful outcomes. Clarma Capital prefers companies with clearly defined exit plans, ideally through acquisitions or mergers, ensuring that their investments align with long-term growth and sustainability.
Martyn Eeles - Managing Partner & Founder. Martyn has extensive experience in venture capital and life sciences, having led numerous successful investments in the sector.
Clara Ezed - Partner. Clara brings a wealth of knowledge in healthcare investments, focusing on early-stage companies.
Milos Milicsevics - Partner. Milos has a strong background in biotech and has been involved in various successful funding rounds.
Dr. László Szabó - M.D. Venture Partner. Dr. Szabó has a medical background and provides valuable insights into healthcare investments.
Alain Bindels - Venture Partner. Alain has experience in both venture capital and operational roles within life sciences companies.
Mary Jo Gorman, MD - Senior Advisor. Dr. Gorman offers expertise in medical devices and healthcare innovation.
Okeibuno Okonkwo, MD - Senior Advisor. Dr. Okonkwo provides insights into clinical applications and healthcare strategies.
To pitch to Clarma Capital, founders should send an email to info@clarmacapital.com. It is important to include a comprehensive pitch deck that outlines the business model, market opportunity, and team qualifications. Response times may vary, so founders should be prepared for potential follow-up discussions.
What are Clarma Capital's investment criteria?
Clarma Capital focuses on seed and early-stage investments in European life sciences companies. They seek startups developing regulated products grounded in solid scientific principles, with significant addressable markets and capable management teams.
How can founders pitch to Clarma Capital?
Founders can reach out to Clarma Capital via email at info@clarmacapital.com. It is advisable to include a detailed pitch deck outlining the business model, market opportunity, and team qualifications.
What makes Clarma Capital different from other investors?
Clarma Capital emphasizes collaboration with incubators and academic institutions, which enhances their ability to identify and support promising life sciences startups. Their focus on scientific rigor and clear exit strategies sets them apart.
What is Clarma Capital's geographic focus?
The firm primarily invests in European life sciences startups, with a strong presence in countries such as the UK, Switzerland, and Ireland.
What is the typical check size for investments?
While specific check sizes are not disclosed, Clarma Capital focuses on seed and early-stage investments, which typically range from hundreds of thousands to several million euros.
What kind of post-investment involvement does Clarma Capital have?
Clarma Capital actively engages with portfolio companies, providing support through mentorship, access to networks, and strategic guidance to help them achieve their growth objectives.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.